Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery

International Journal of Pharmaceutics

Volumn 323, Issue 1-2, 2006, Pages 117-124

  Kumar, Amit ^a   Lahiri, Sitanshu S ^b   Singh, Harpal ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY DELHI   (India)

^b INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

Diabetes; Hydrogel microparticles; Insulin; Oral drug delivery

Indexed keywords

COPOLYMER; INSULIN; MACROGOL; METHACRYLIC ACID; METHACRYLIC ACID DERIVATIVE; POLY(ETHYLENE GLYCOL)DIMETHACRYLATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALYST; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; ESTERIFICATION; GASTROINTESTINAL TRACT; GLUCOSE BLOOD LEVEL; HYDROGEL; MOLECULAR WEIGHT; NONHUMAN; PARTICLE SIZE; PH; POLYMERIZATION; PRIORITY JOURNAL; RAT; SIMULATION;

ACRYLATES; ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DRUG DELIVERY SYSTEMS; HYDROGELS; HYDROGEN-ION CONCENTRATION; INSULIN; METHACRYLATES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYMETHACRYLIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; WATER;

EID: 33748690106     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.05.050     Document Type: Article

References (42)

1. Agarwal V., Reddy K.I., and Khan A.M. Polymethacrylate based microparticles of insulin for oral delivery: preparation and in vitro dissolution stability in the presence of enzyme inhibitors. Int. J. Pharm. 225 (2001) 31-39
2. Aungst B.J. Site dependence and structure-effect relationships for alkylglycosides as transmucosal absorption promoters for insulin. Int. J. Pharm. 105 (1994) 219-225
3. Brand R.M., Duensing G., and Hamel F.G. Iontophoretic delivery of an insulin-mimetic peroxovandium compound. Int. J. Pharm. 146 (1997) 115-122
4. Boucaud A., Garrigue M.A., Machet L., Vaillant L., and Patat F. Effect of sonication parameters on transdermal delivery of insulin to hairless rats. J. Controlled Release 81 (2002) 113-119
5. Calceti P., Salmaso S., Walker G., and Bernkop-Schurch A. Development and in vivo evaluation of an oral insulin-PEG delivery system. Eur. J. Pharm. Sci. 22 (2004) 315-323
6. Coudhari K.B., Labhasetwar V., and Dorle A.K. Liposomes as carrier for oral administration of insul: effect of formulation factors. J. Microencapsul. 11 (1994) 319-325
7. Cruise G.M., Hergre O.D., Scharp D.S., and Hubbell J.A. A sensitivity study of the key parameters in the interfacial photopolymerisation of poly(ethylene glycol) diacrylate upon porcine islets. Biotechnol. Bioeng. 57 (1998) 655-665
8. Foss A.C., Goto T., Morishita M., and Peppas N.A. Development of acrylic-based copolymers for oral insulin delivery. Eur. J. Pharm. Sci. 57 (2004) 163-169
9. Foss A.C., and Peppas N.A. Investigation of cytotoxicity and insulin transport of acrylic-based copolymer protein delivery systems in contact with caco-2 cultures. Eur. J. Pharm. Biopharm. 57 (2004) 447-455
10. Gerardo P.C., and Edith M. Oral insulin delivery. Adv. Drug Deliv. Rev. 35 (1999) 249-257
11. Iwanaga K., Ono S., Narioka K., Morimoto K., Masawo K., Yamashita S., Nango M., and Oku N. Oral delivery of insulin using surface coating liposomes. Improvement of stability of insulin in gi tract. Int. J. Pharm. 157 (1997) 73-80
12. Joshi M., and Misra A. Dry powder inhalation of liposomal ketotifen fumarate: formulation and characterization. Int. J. Pharm. 223 (2001) 15-27
13. Kleir J., and Peppas N.A. Complex-forming hydrogels sensitive to physiological conditions. Proc. Adv. Biomed. Polym. 1 (1989) 107-109
14. Kimura T., Sato K., Sugimoto K., Tao R., Murakami T., Kurosaki Y., and Nakayama T. Oral administration of insulin as poly(vinyl alcohol)-gel spheres in diabetic rats. Biol. Pharm. Bull. 19 (1996) 187-900
15. Kublik H., and Vidgren M.T. Nasal delivery systems and their effect on deposition and absorption. Adv. Drug Deliv. Rev. 29 (1998) 157-177
16. Kanikkannan N., Singh J., and Ramarao P. Transdermal iontophoretic delivery of bovine insulin and monomeric human insulin analogue. J. Controlled Release 59 (1999) 99-105
17. Kisel M.A., Kulik L.N., Tsybovsky I.S., Vlasov A.P., Vorob'yov M.S., Kholodova E.A., and Zabarovskaya Z.V. Liposomes with phosphatidylethanol as acarrier for oral delivery of insulin: studies in the rat. Int. J. Pharm. 216 (2001) 105-114
18. Lee H.J. Protein drug oral delivery: the recent progress. Arch. Pharm. Res. 25 (2002) 572-584
19. Lee V.H.L., Kashi S.D., Grass G.M., and Rubas W. Oral route of protein and peptide drug delivery. In: Lee V.H.L. (Ed). Peptide and Protein Drug Delivery (2000), Marcel Dekker, New York 691-740
20. Lowman A.M., Morishita M., Kajita M., Naggi T., and Peppas N.A. Oral delivery of insulin using pH responsive complexation gels. J. Pharm. Sci. 88 (1999) 933-937
21. Lowman A.M., and Peppas N.A. Molecular analysis of interpolymer complexation in graft copolymer networks. Polymer 41 (2000) 73-80
22. Madsen F., and Peppas N.A. Complexation graft copolymer networks: swelling properties, calcium binding and proteolytic enzyme inhibition. Biomaterials 20 (1999) 1701-1708
23. Morcöl T., Nagappan P., Nerenbaum L., Mitchell A., and Bell S.J.D. Calcium phosphate-PEG-insulin-casein (CAPIC) as oral delivery systems for insulin. Int. J. Pharm. 277 (2004) 91-97
24. Morishita I., Morishita M., Takayama K., Machida Y., and Nagi T. Hypoglycemic effect of novel oral spheres of insulin with protease inhibitor in normal and diabetic rats. Int. J. Pharm. 78 (1992) 9-16
25. Morishita M., Goto T., Peppas N.A., Joseph J.I., Torjman M.A., Munsick C., Nakamura K., Yamagata T., Takayama K., and Lowman A.M. Mucosal insulin delivery system based on complexation hydrogels: effect of particle size on insulin enteral absorption. J. Controlled Release 97 (2004) 115-124
26. Nakamura K., Murray R.J., Joseph J.I., Peppas N.A., Morishita M., and Lowman A.M. Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics. J. Controlled Release 95 (2004) 589-599
27. Oliva A., Farina J.B., and Llabres M. Influence of temperature and shaking on stability of insulin preparations: degradation kinetics. Int. J. Pharm. 143 (1996) 163-170
28. Onuli Y., Morishita M., Takayama K., Tokiwa S., Chiba Y., Isowa K., and Nagai T. In vivo effects of highly purified docosahexaenoic acid on rectal insulin absorption. Int. J. Pharm. 198 (2000) 147-156
29. Pathak C.P., Sawhney A.S., and Hubbell J.A. Rapid photopolymerisation of immunoprotective gels in contact with cell and tissue. J. Am. Chem. Soc. 114 (1992) 8311-8312
30. Peppas N.A., Keys K.B., Torres-lugo M., and Lowman A.M. Poly(ethylene glycol) containing hydrogels in drug delivery. J. Controlled Release 62 (1999) 81-87
31. Peppas N.A., Bures P., Leobndung W., and Ichikawa H. Hydrogels in pharmaceuticals formulations. Eur. J. Pharm. Biopharm. 50 (2000) 27-46
32. Peppas N.A. Devices based on intelligent biopolymers for oral protein delivery. Int. J. Pharm. 277 (2004) 11-17
33. Preswich G., Luo Y., and Kirker K. Crosslinked hyaluronic acid hydrogel films: new biomaterials for drug delivery. J. Controlled Release 69 (2000) 169-184
34. Sastry S.V., Nyshadham J.R., and Fix J.A. Recent technology advances in oral drug delivery-a review. PSTT 3 (2000) 138-145
35. Senel S., Capan Y., Sargon M.F., Ikinci G., Solpan D., Guven O., Bodde H.E., and Hincal A.A. Enhancement of transmucosal permeation of morphine sulfate by sodium glycodeoxycholate in vitro. J. Controlled Release 45 (1997) 153-162
36. Shein W.C. Oral peptide and protein delivery: unfulfilled promises?. Drug Discovery Today 8 (2003) 607-608
37. Surendrakumar K., Martyn G.P., Hodgers E.C.M., Jansen M., and Blair J.A. Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs. J. Controlled Release 91 (2003) 385-394
38. Torres-lugo M., Garcia M., Record R., and Peppas N.A. pH sensitive hydrogel as gastrointestinal tract absorption enhancers: transport mechanisms of salmon calcitonin and other model molecules using the caco-2 cell model. Biotechnol. Prog. 18 (2002) 612-616
39. Trenktrog T., Muller B.W., Specht F.M., and Seifert J. Enteric coated insulin pellets: development, drug release and in vivo evaluation. Eur. J. Pharm. Sci. 58 (1996) 538-548
40. Trotta M., Cavalli R., Carlotti R., Battagalia L., and Debernardi F. Solid lipid microparticles carrying insulin formed by solvent-in water emulsion-diffusion technique. Int. J. Pharm. 288 (2005) 281-288
41. Yomota C., Yoshii Y., Takahata T., and Okada S. Separation of B-3 monodesamidoinsulin from human insulin by high-performance liquid chromatography under alkaline conditions. J. Chromatogr. A 721 (1996) 89-96
42. Zimmermann E., and Muller R. Electrolyte and pH-stabilities of aqueous solid lipid nanoparticle dispersion in artificial gastrointestinal media. Eur. J. Pharm. Biopharm. 52 (2001) 203-210